Jump to content Jump to main menu Jump to sub menu

Latest News

10 July 2015 - Multi-national asthma study award

QED announces the award of a multi-national asthma study for a European biotech company.The study which will be conducted in 5 countries is set out to recruit 200 patients. Chief Executive Thomas Ogorka comments:
“It is great to see that lean biotech companies are looking out for lean CROs with international capabilities. In an environment where mergers and acquisitions reduce variety in our industry and leave innovative biotech companies with little choice to find a matching service partner, QED with its unique global delivery model is standing out from the crowd. We are thrilled to service yet another very promising Sponsor.”